This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Klinikum Der Universitat Munchen, Leibniz Institute for Natural Product Research and Infection Biology—hans Knoll Institute, Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie E.v. Hans-Knoell-Institute (Hki). Active years: 2015-2021.
Company Filing History:
1 out of 4 
1 out of 1 
1 out of 1 
Years Active: 2015-2021
Title: Innovations and Contributions of Axel Brakhage
Introduction
Axel Brakhage is a notable inventor based in Weimar, Germany. He has made significant contributions to the field of antimicrobial compounds and their applications in treating infectious diseases. With a total of three patents to his name, Brakhage's work focuses on innovative solutions to combat serious health issues.
Latest Patents
Brakhage's latest patents include groundbreaking research on antimicrobial compounds aimed at treating mammalian infections. His inventions specifically address diseases caused by mycobacteria, such as tuberculosis, Buruli ulcer, and leprosy. The patents detail the generation of a new series of benzothiazinone compounds designed to overcome existing treatment challenges. Additionally, his research provides methods for the selective activation and analysis of specific CD4 T cells, which are crucial for immune response.
Career Highlights
Throughout his career, Axel Brakhage has worked with esteemed organizations, including Miltenyi Biotec GmbH and the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute. His work has been instrumental in advancing the understanding and treatment of infectious diseases.
Collaborations
Brakhage has collaborated with notable colleagues such as Alexander Scheffold and Petra Bacher. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field of microbiology.
Conclusion
Axel Brakhage's contributions to antimicrobial research and his innovative patents highlight his commitment to improving health outcomes. His work continues to influence the treatment of infectious diseases, showcasing the importance of innovation in medical science.